Bellevue Asset Management AG has appointed André Rüegg as its chief executive, replacing Hans-Peter Diener who is moving to the parent company, Bellevue Group AG. The Swiss asset management company manages BB Biotech AG, a closed-end, listed holding company that invests in biotech companies globally.
Mr Rüegg was previously deputy CEO and head of sales and marketing at Bellevue Asset Management. As the new CEO, he will join the executive board of the parent company.
Copyright 2011 Evernow Publishing Ltd